Who owns ALIGOS THERAPEUTICS INC?
- Ticker: ALGS
- CUSIP Number: 01626l204
Tip: Access positions for across all investors
Analyze quarterly positions in Aligos Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Aligos Therapeutics stock
Who bought or sold ALIGOS THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Deep Track Capital | 444k | $4.1M | 0% | Dec 2025 |
|
| Alyeska Investment Group | 412k | $3.8M | 0% | Dec 2025 |
|
| Sio Capital Management | 336k | $3.1M | 0% | Dec 2025 |
|
| Woodline Partners | 289k | $2.7M | -38% | Dec 2025 |
|
| Marshall Wace | 269k | $2.5M | 100% | Dec 2025 |
|
| Vanguard Group | 200k | $1.9M | 17% | Dec 2025 |
|
| SummitTX Capital | 139k | $1.3M | 100% | Dec 2025 |
|
| Renaissance Technologies | 85k | $796k | 55% | Dec 2025 |
|
| Baker Bros. Advisors | 83k | $774k | 0% | Dec 2025 |
|
| Two Sigma Investments | 81k | $752k | 107% | Dec 2025 |
|
| Hillhouse Capital Advisors | 76k | $711k | 0% | Dec 2025 |
|
| Verition Fund Management | 71k | $664k | 100% | Dec 2025 |
|
| LPL Financial | 66k | $615k | 20% | Dec 2025 |
|
| Citadel Advisors | 52k | $483k | 403% | Dec 2025 |
|
| Geode Capital Management | 48k | $445k | 1% | Dec 2025 |
|
| Jane Street | 24k | $226k | 100% | Dec 2025 |
|
| XTX Topco | 23k | $215k | 100% | Dec 2025 |
|
| Quest Partners | 14k | $129k | 105% | Dec 2025 |
|
| BlackRock | 13k | $122k | 0% | Dec 2025 |
|
| Two Sigma Advisers | 13k | $121k | 100% | Dec 2025 |
|
| DRW Holdings | 12k | $111k | 100% | Dec 2025 |
|
| Hrt Financial | 11k | $106k | 100% | Dec 2025 |
|
| Rockefeller Capital Management | 10k | $93k | 900% | Dec 2025 |
|
| FMR | 5.0k | $46k | 100% | Dec 2025 |
|
| Golden State Wealth Management | 2.7k | $25k | 0% | Dec 2025 |
|
| Wells Fargo & Company | 1.5k | $14k | -53% | Dec 2025 |
|
| White Bay PT | 500.00 | $4.7k | 100% | Dec 2025 |
|
| Global Retirement Partners | 400.00 | $3.7k | -50% | Dec 2025 |
|
| UBS Group | 364.00 | $3.4k | -98% | Dec 2025 |
|
| Tower Research Capital | 39.00 | $363.000300 | -91% | Dec 2025 |
|
| SBI Securities | 26.00 | $242.000200 | 0% | Dec 2025 |
|
| Zrc Wealth Management | 4.00 | $30.000000 | 0% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 3.00 | $27.999900 | 0% | Dec 2025 |
|
Who sold out of Aligos Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Readystate Asset Management | Sep 2025 | 203k | $2.0M |
| Adage Capital Partners GP | Sep 2025 | 140k | $1.4M |
| Squarepoint Ops | Sep 2025 | 31k | $299k |
| Susquehanna International | Sep 2025 | 10k | $99k |
| NorthCrest Asset Manangement | Dec 2025 | 10k | $84k |
| Barclays | Sep 2025 | 15.00 | $147.000000 |